...
首页> 外文期刊>Allergy >Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.
【24h】

Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.

机译:前列腺素E通过EP1 / EP3受体增强免疫刺激的组胺从人外周血衍生的肥大细胞中释放。

获取原文
获取原文并翻译 | 示例

摘要

Background: Mast cells cultured from human peripheral blood have been widely used to study human mast cell function. Prostanoids are the important regulators of mast cell activity, however, there were no reports about the class of prostanoid receptors expressed on such cultured cells. Aims: The present study was to characterize pharmacologically the prostanoid receptors by investigating the effects of prostanoid receptor agonists on the immunoglobulin E (IgE)-mediated histamine release from the cultured mast cells. Methods: Mast cells cultured from human progenitor cells in peripheral blood were sensitized with human myeloma IgE, and then challenged with anti-human IgE following pretreatment with diverse prostanoid receptor agonists. The histamine content in supernatants and cell pellets were measured by histamine auto-analyzer. Results: Of the prostanoid receptor agonists tested, the prostaglandin E(2) (PGE(2)) receptor (EP receptor) agonist PGE(2) (10(-7) to 10(-11) M) produced concentration-related potentiation of IgE-mediated histamine release from the cultured mast cells. Sulprostone, an EP(1)/EP(3) agonist, SC-46275, a selective EP(3) agonist, and 11-deoxy-PGE(1), a selective EP(2)/EP(3)/EP(4) agonist also caused a significant increase in histamine release induced by anti-IgE. BW245C, fluprostone, cicaprost and U46619 for the prostaglandin D(2), F(2alpha), I(2), and thromboxane A(2) receptors respectively, and the EP(2)/EP(4) receptor agonist butaprost had little effect on anti-IgE stimulated histamine release from mast cells. Conclusions: The present results suggest that PGE(2) potentiates the IgE-mediated histamine release from the cultured mast cell via EP(3) and/or EP(1) receptors.
机译:背景:从人体外周血培养的肥大细胞已被广泛用于研究人体肥大细胞的功能。前列腺素是肥大细胞活性的重要调节剂,但是,没有关于在这样的培养细胞上表达的前列腺素受体的类别的报道。目的:本研究旨在通过研究前列腺素受体激动剂对免疫球蛋白E(IgE)介导的培养肥大细胞释放组胺的作用,从药理上表征前列腺素受体。方法:用人骨髓瘤IgE敏化外周血中人祖细胞培养的肥大细胞,然后用多种类前列腺素受体激动剂预处理后用抗人IgE攻击。通过组胺自动分析仪测量上清液和细胞沉淀中的组胺含量。结果:在所测试的前列腺素受体激动剂中,前列腺素E(2)(PGE(2))受体(EP受体)激动剂PGE(2)(10(-7)至10(-11)M)产生了浓度相关的增强作用IgE介导的组胺从培养的肥大细胞中释放。 Sulprostone,一种EP(1)/ EP(3)激动剂,SC-46275,一种选择性EP(3)激动剂,和11-脱氧-PGE(1),一种选择性EP(2)/ EP(3)/ EP( 4)激动剂还引起抗IgE诱导的组胺释放的显着增加。前列腺素D(2),F(2alpha),I(2)和血栓烷A(2)受体的BW245C,氟哌啶酮,西卡前列素和U46619以及EP(2)/ EP(4)受体激动剂Butaprost很少对抗IgE刺激的组胺从肥大细胞释放的影响。结论:目前的结果表明PGE(2)增强了IgE介导的组胺通过EP(3)和/或EP(1)受体从肥大细胞中释放的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号